Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2007 1
2008 1
2009 2
2010 5
2012 1
2013 2
2014 2
2015 2
2018 3
2019 2
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.
Youale J, Bigot K, Kodati B, Jaworski T, Fan Y, Nsiah NY, Pappenhagen N, Inman DM, Behar-Cohen F, Bordet T, Picard E. Youale J, et al. Among authors: bordet t. Int J Mol Sci. 2022 Oct 22;23(21):12753. doi: 10.3390/ijms232112753. Int J Mol Sci. 2022. PMID: 36361544 Free PMC article.
[Anti-TNF-α in the treatment of non-infectious uveitis].
Hoogewoud F, Kowalczuk L, Bousquet E, Brézin A, Touchard E, Buggage R, Bordet T, Behar-Cohen F. Hoogewoud F, et al. Among authors: bordet t. Med Sci (Paris). 2020 Oct;36(10):893-899. doi: 10.1051/medsci/2020160. Epub 2020 Oct 7. Med Sci (Paris). 2020. PMID: 33026332 Free article. Review. French.
Gene Therapy for Uveitis.
Buggage RR, Bordet T. Buggage RR, et al. Among authors: bordet t. Int Ophthalmol Clin. 2021 Oct 1;61(4):249-270. doi: 10.1097/IIO.0000000000000369. Int Ophthalmol Clin. 2021. PMID: 34584061 No abstract available.
Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration.
Bigot K, Gondouin P, Bénard R, Montagne P, Youale J, Piazza M, Picard E, Bordet T, Behar-Cohen F. Bigot K, et al. Among authors: bordet t. Pharmaceutics. 2020 Sep 1;12(9):836. doi: 10.3390/pharmaceutics12090836. Pharmaceutics. 2020. PMID: 32882879 Free PMC article.
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome.
Collaud F, Bortolussi G, Guianvarc'h L, Aronson SJ, Bordet T, Veron P, Charles S, Vidal P, Sola MS, Rundwasser S, Dufour DG, Lacoste F, Luc C, Wittenberghe LV, Martin S, Le Bec C, Bosma PJ, Muro AF, Ronzitti G, Hebben M, Mingozzi F. Collaud F, et al. Among authors: bordet t. Mol Ther Methods Clin Dev. 2018 Dec 31;12:157-174. doi: 10.1016/j.omtm.2018.12.011. eCollection 2019 Mar 15. Mol Ther Methods Clin Dev. 2018. PMID: 30705921 Free PMC article.
TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.
Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM. Schaller S, et al. Among authors: bordet t. J Pharmacol Exp Ther. 2010 Jun;333(3):696-706. doi: 10.1124/jpet.110.167486. Epub 2010 Mar 9. J Pharmacol Exp Ther. 2010. PMID: 20215409 Free article.
28 results